Drugs / JST-010
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06943378 Comparator | May 2025 → Apr 2027 expected | — | Just-Evotec Biologics | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JST-010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06943378 ↗ |
| Modality | Monoclonal antibody | “a Monoclonal Antibody, JST-010” NCT06943378 ↗ |
| Route | Intramuscular | “administered IM” NCT06943378 ↗ |